Minyan Chen
Overview
Explore the profile of Minyan Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu Y, Cai Q, Li J, Guo W, Chen L, Chen M, et al.
Breast Cancer Res Treat
. 2025 Jan;
PMID: 39755988
Purpose: Age stratification influences the clinicopathological features and survival outcomes of breast cancer. We aimed to understand the effect of age on gene variants in young Chinese women with breast...
2.
Chen X, Cai Q, Deng L, Chen M, Xu M, Chen L, et al.
Front Immunol
. 2024 Dec;
15:1465862.
PMID: 39628488
Introduction: The association between inflammatory blood markers (IBMs) (monocyte-to-lymphocyte ratio [MLR], neutrophil-to-lymphocyte ratio [NLR], and platelet-to-lymphocyte ratio [PLR]) and breast cancer has been extensively studied. However, the predictive role of...
3.
Nie Q, Zhang W, Lin S, Huang M, Li Y, Qiu Y, et al.
Cancer Sci
. 2024 Oct;
115(12):4064-4073.
PMID: 39401980
Mitochondrial DNA (mtDNA) variations affect the efficiency of the electron transport chain and production of reactive oxygen species, contributing to carcinogenesis. The D-loop region of mtDNA has emerged as a...
4.
Zhang T, Chen M
Int J Health Plann Manage
. 2024 Oct;
40(1):204-223.
PMID: 39385320
Background: A limited benefit package for outpatient care in Chinese universal health coverage led to high out-of-pocket outpatient payments, and even medical impoverishment. The outpatient pooling fund model was introduced...
5.
Li Y, Lin Y, Tang Y, Jiang M, Chen X, Chen H, et al.
Cell Death Dis
. 2024 Jul;
15(7):516.
PMID: 39025830
Tumour metabolic reprogramming is pivotal for tumour survival and proliferation. Investigating potential molecular mechanisms within the heterogeneous and clinically aggressive triple-negative breast cancer (TNBC) subtype is essential to identifying novel...
6.
Li J, He P, Cai Q, Chen L, Wang Y, Cai W, et al.
J Cancer Res Clin Oncol
. 2024 Jun;
150(6):322.
PMID: 38914840
Purpose: Limited data are available regarding the partner and localizer of BRCA2 (PALB2) in Chinese patients with early breast cancer. This study aimed to assess the spectrum and characteristics of...
7.
Lin Y, Li Y, Chen X, Jin X, Jiang M, Xiao H, et al.
Biol Direct
. 2024 Jun;
19(1):42.
PMID: 38831379
Triple-negative breast cancer (TNBC) is more aggressive and has a higher metastasis rate compared with other subtypes of breast cancer. Due to the lack of drug-targetable receptors, chemotherapy is now...
8.
Chen H, Chen M, Zeng B, Tang L, Nie Q, Jin X, et al.
Front Immunol
. 2024 May;
15:1284579.
PMID: 38690279
Introduction: The programmed cell death (PCD) pathway plays an important role in restricting cancer cell survival and proliferation. However, limited studies have investigated the association between genetic variants in the...
9.
Wang Y, Cai W, He P, Cai Q, Huang J, Liu S, et al.
Int J Cancer
. 2024 Apr;
155(3):545-557.
PMID: 38561936
Recombinant human granulocyte colony-stimulating factor (G-CSF) administration in patients with cancer and coronavirus disease (COVID-19) remains controversial. Concerns exist that it may worsen COVID-19 outcomes by triggering an inflammatory cytokine...
10.
Zhang T, Chen M
Front Public Health
. 2024 Mar;
12:1357114.
PMID: 38500728
Objective: The implementation of the outpatient pooling scheme in China has substantially elevated the compensation levels for outpatient expenses. This study aims to assess whether socioeconomically disadvantaged enrollees benefit proportionally...